226 related articles for article (PubMed ID: 29096609)
1. Asthma-COPD overlap is not a homogeneous disorder: further supporting data.
Pérez-de-Llano L; Cosio BG;
Respir Res; 2017 Nov; 18(1):183. PubMed ID: 29096609
[TBL] [Abstract][Full Text] [Related]
2. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease.
Katoh S; Ikeda M; Shirai R; Abe M; Ohue Y; Kobashi Y; Oka M
J Asthma; 2018 Oct; 55(10):1052-1058. PubMed ID: 29035604
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD.
Chen FJ; Lin GP; Huang XY; Liu YL; Zeng ZM; Guo YB
Int J Chron Obstruct Pulmon Dis; 2019; 14():2663-2671. PubMed ID: 31819399
[TBL] [Abstract][Full Text] [Related]
5. Combined Assessment of Serum Periostin and YKL-40 May Identify Asthma-COPD Overlap.
Shirai T; Hirai K; Gon Y; Maruoka S; Mizumura K; Hikichi M; Holweg C; Itoh K; Inoue H; Hashimoto S
J Allergy Clin Immunol Pract; 2019 Jan; 7(1):134-145.e1. PubMed ID: 29981861
[TBL] [Abstract][Full Text] [Related]
6. Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD.
Wang J; Lv H; Luo Z; Mou S; Liu J; Liu C; Deng S; Jiang Y; Lin J; Wu C; Liu X; He J; Jiang D
Respir Res; 2018 Mar; 19(1):47. PubMed ID: 29580282
[TBL] [Abstract][Full Text] [Related]
7. Relationship of Serum Levels of IL-17, IL-18, TNF-
Kubysheva N; Boldina M; Eliseeva T; Soodaeva S; Klimanov I; Khaletskaya A; Bayrasheva V; Solovyev V; Villa-Vargas LA; Ramírez-Salinas MA; Salinas-Rosales M; Ovsyannikov DY; Batyrshin I
Mediators Inflamm; 2020; 2020():4652898. PubMed ID: 32733164
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of a New Algorithm to Identify Asthma-COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease.
Pérez de Llano L; Cosío BG; Miravitlles M; Plaza V;
Arch Bronconeumol (Engl Ed); 2018 Apr; 54(4):198-204. PubMed ID: 29229474
[TBL] [Abstract][Full Text] [Related]
9. Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?
Cosío BG; Pérez de Llano L; Lopez Viña A; Torrego A; Lopez-Campos JL; Soriano JB; Martinez Moragon E; Izquierdo JL; Bobolea I; Callejas J; Plaza V; Miravitlles M; Soler-Catalunya JJ;
Eur Respir J; 2017 May; 49(5):. PubMed ID: 28461299
[TBL] [Abstract][Full Text] [Related]
10. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
[TBL] [Abstract][Full Text] [Related]
11. Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort.
Park HY; Lee SY; Kang D; Cho J; Lee H; Lim SY; Yoon HI; Ra SW; Kim KU; Oh YM; Sin DD; Lee SD; Park YB
Respir Res; 2018 Mar; 19(1):36. PubMed ID: 29499758
[TBL] [Abstract][Full Text] [Related]
12. Disease burden of eosinophilic airway disease: Comparing severe asthma, COPD and asthma-COPD overlap.
Hiles SA; Gibson PG; McDonald VM
Respirology; 2021 Jan; 26(1):52-61. PubMed ID: 32428971
[TBL] [Abstract][Full Text] [Related]
13. Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease.
Han SS; Lee WH; Hong Y; Kim WJ; Yang J; Lim MN; Lee SJ; Kwon JW
J Asthma; 2016 Aug; 53(6):583-8. PubMed ID: 27104648
[TBL] [Abstract][Full Text] [Related]
14. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.
Golpe R; Martín-Robles I; Sanjuán-López P; Pérez-de-Llano L; González-Juanatey C; López-Campos JL; Arellano-Orden E
Int J Chron Obstruct Pulmon Dis; 2017; 12():2639-2646. PubMed ID: 28979110
[TBL] [Abstract][Full Text] [Related]
15. ACO: Time to move from the description of different phenotypes to the treatable traits.
Toledo-Pons N; van Boven JFM; Román-Rodríguez M; Pérez N; Valera Felices JL; Soriano JB; Cosío BG
PLoS One; 2019; 14(1):e0210915. PubMed ID: 30677059
[TBL] [Abstract][Full Text] [Related]
16. The relationship between inflammatory markers and spirometric parameters in ACOS, Asthma, and COPD.
Uzan GC; Borekci S; Doventas YE; Koldas M; Gemicioglu B
J Asthma; 2020 Dec; 57(12):1273-1279. PubMed ID: 31403365
[No Abstract] [Full Text] [Related]
17. Eicosanoids metabolized through LOX distinguish asthma-COPD overlap from COPD by metabolomics study.
Cai C; Bian X; Xue M; Liu X; Hu H; Wang J; Zheng SG; Sun B; Wu JL
Int J Chron Obstruct Pulmon Dis; 2019; 14():1769-1778. PubMed ID: 31496676
[TBL] [Abstract][Full Text] [Related]
18. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Blood Biomarkers in Patients with Chronic Obstructive Pulmonary Disease (COPD) and with Asthma-COPD Overlap (ACO).
Gava G; Núñez A; Esquinas C; Sarasate M; Loeb E; Pirina P; Miravitlles M; Barrecheguren M
COPD; 2020 Jun; 17(3):306-310. PubMed ID: 32380914
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma.
Kolsum U; Ravi A; Hitchen P; Maddi S; Southworth T; Singh D
Respir Res; 2017 Apr; 18(1):73. PubMed ID: 28446172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]